Market Research Logo

Inhalers - Medical Devices Pipeline Assessment, 2019

Inhalers - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2019 provides an overview of Inhalers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Inhalers Overview
  • Products under Development
    • Inhalers - Pipeline Products by Stage of Development
      • Table Figure 1: Inhalers - Pipeline Products by Stage of Development
      • Table Inhalers - Pipeline Products by Stage of Development
    • Inhalers - Pipeline Products by Segment
      • Table Figure 2: Inhalers - Pipeline Products by Segment
      • Table Inhalers - Pipeline Products by Segment
    • Inhalers - Pipeline Products by Territory
      • Table Figure 3: Inhalers - Pipeline Products by Territory
      • Table Inhalers - Pipeline Products by Territory
    • Inhalers - Pipeline Products by Regulatory Path
      • Table Figure 4: Inhalers - Pipeline Products by Regulatory Path
      • Table Inhalers - Pipeline Products by Regulatory Path
    • Inhalers - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Inhalers - Pipeline Products by Estimated Approval Date
      • Table Inhalers - Pipeline Products by Estimated Approval Date
    • Inhalers - Ongoing Clinical Trials
      • Table Figure 6: Inhalers - Ongoing Clinical Trials
      • Table Inhalers - Ongoing Clinical Trials
  • Inhalers - Pipeline Products under Development by Companies
    • Inhalers Companies - Pipeline Products by Stage of Development
      • Table Inhalers Companies - Pipeline Products by Stage of Development
    • Inhalers - Companies Pipeline Products by Stage of Development
      • Table Inhalers - Companies Pipeline Products by Stage of Development
  • Inhalers Companies and Product Overview
    • Acorda Therapeutics Inc Company Overview
      • Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table INBRIJA - Product Status
        • Table INBRIJA - Product Description
        • Table PLUMIAZ Nasal Spray Device - Product Status
        • Table PLUMIAZ Nasal Spray Device - Product Description
    • Adamis Pharmaceuticals Corp Company Overview
      • Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taper DPI - Product Status
        • Table Taper DPI - Product Description
    • Advent Pharmaceuticals Pty Ltd Company Overview
      • Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table g60 Dry Powder Inhaler - Product Status
        • Table g60 Dry Powder Inhaler - Product Description
    • Aespira Ltd. Company Overview
      • Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table resQhaler - Product Status
        • Table resQhaler - Product Description
    • AKELA Pharma Inc. (Inactive) Company Overview
      • AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fentanyl TAIFUN Inhaler - Product Status
        • Table Fentanyl TAIFUN Inhaler - Product Description
    • Alexza Pharmaceuticals Inc Company Overview
      • Alexza Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alexza Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Staccato System - Disposable Single Dose - Product Status
        • Table Staccato System - Disposable Single Dose - Product Description
        • Table Staccato System - Multiple Dose - Product Status
        • Table Staccato System - Multiple Dose - Product Description
    • Aradigm Corp Company Overview
      • Aradigm Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aradigm Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerx Pure Nicotine Inhaler - Product Status
        • Table Aerx Pure Nicotine Inhaler - Product Description
    • AstraZeneca Plc Company Overview
      • AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duaklir Genuair Metered Dose Inhaler - Product Status
        • Table Duaklir Genuair Metered Dose Inhaler - Product Description
    • Bayer AG Company Overview
      • Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ciprofloxacin Dry Powder Inhaler - Product Status
        • Table Ciprofloxacin Dry Powder Inhaler - Product Description
    • Bellerophon Therapeutics Inc Company Overview
      • Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mark2 Device - Product Status
        • Table Mark2 Device - Product Description
    • Bespak Europe Ltd Company Overview
      • Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAL020 Metered Dose Inhaler Valve - Product Status
        • Table VAL020 Metered Dose Inhaler Valve - Product Description
    • Boehringer Ingelheim GmbH Company Overview
      • Boehringer Ingelheim GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boehringer Ingelheim GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Respimat Inhaler - Product Status
        • Table Next Generation Respimat Inhaler - Product Description
    • Circassia Pharmaceuticals Plc Company Overview
      • Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tiotropium bromide DPI - Product Status
        • Table Tiotropium bromide DPI - Product Description
    • Drexel University Company Overview
      • Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table BREATHE Inhaler - Product Status
        • Table BREATHE Inhaler - Product Description
    • Eli Lilly and Co Company Overview
      • Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nasal Glucagon Delivery System - Product Status
        • Table Nasal Glucagon Delivery System - Product Description
    • FocusStart LLC Company Overview
      • FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Inhaler - Product Status
        • Table Smart Inhaler - Product Description
    • GlaxoSmithKline Plc Company Overview
      • GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gemini Multi-Dose Combination Inhaler - Product Status
        • Table Gemini Multi-Dose Combination Inhaler - Product Description
    • Lupin Pharmaceuticals Inc Company Overview
      • Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tiotropium DPI - Product Status
        • Table Tiotropium DPI - Product Description
    • MannKind Corp Company Overview
      • MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dreamboat - Product Status
        • Table Dreamboat - Product Description
        • Table Treprostinil Technosphere - Product Status
        • Table Treprostinil Technosphere - Product Description
    • Medihale Ltd (Inactive) Company Overview
      • Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Toucan Multi-Dose Inhaler - Product Status
        • Table Toucan Multi-Dose Inhaler - Product Description
    • Monash University Company Overview
      • Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerosol Delivery System - Product Status
        • Table Aerosol Delivery System - Product Description
    • Nektar Therapeutics Company Overview
      • Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nektar Dry Powder Inhaler - Amikacin - Product Status
        • Table Nektar Dry Powder Inhaler - Amikacin - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Inhaler System - Product Status
        • Table Smart Inhaler System - Product Description
    • Novartis AG Company Overview
      • Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Breezhaler Inhaler - Product Status
        • Table Next Generation Breezhaler Inhaler - Product Description
    • Ology Bioservices Inc Company Overview
      • Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GelVac Intranasal Powder Vaccine Delivery System - Product Status
        • Table GelVac Intranasal Powder Vaccine Delivery System - Product Description
        • Table NanoGENT - Product Status
        • Table NanoGENT - Product Description
    • OPKO Health Inc Company Overview
      • OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inspiromatic - Product Status
        • Table Inspiromatic - Product Description
    • OtiTopic LLC Company Overview
      • OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASPRIHALE - Product Status
        • Table ASPRIHALE - Product Description
    • Perrigo Co Plc Company Overview
      • Perrigo Co Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Perrigo Co Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProAir Inhalation Aerosol - Product Status
        • Table ProAir Inhalation Aerosol - Product Description
    • Pharmaxis Ltd Company Overview
      • Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orbital Dry Powder Inhaler - Product Status
        • Table Orbital Dry Powder Inhaler - Product Description
    • Pneuma Respiratory Inc Company Overview
      • Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PNEUMAHALER - Product Status
        • Table PNEUMAHALER - Product Description
    • Resolve Digital Health Inc Company Overview
      • Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breeze Smart Inhaler - Product Status
        • Table Breeze Smart Inhaler - Product Description
    • Respira Therapeutics Inc Company Overview
      • Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RT234 AOS DPI - Product Status
        • Table RT234 AOS DPI - Product Description
    • Sandoz International GmbH Company Overview
      • Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Solis Multi-Dose Dry Powder Inhaler - Product Status
        • Table Solis Multi-Dose Dry Powder Inhaler - Product Description
        • Table Unit-Dose Dry Powder Inhaler - Product Status
        • Table Unit-Dose Dry Powder Inhaler - Product Description
    • Seng Vital International GmbH Company Overview
      • Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table CANNAMED - Product Status
        • Table CANNAMED - Product Description
    • Senzer Ltd Company Overview
      • Senzer Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Senzer Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Candex - Product Status
        • Table Candex - Product Description
    • Sheffield Hallam University Company Overview
      • Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status(Sheffield Hallam University)
        • Table Dry Powder Inhaler - Product Description(Sheffield Hallam University)
    • Softhale NV Company Overview
      • Softhale NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Softhale NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soft Mist Inhaler - Product Status
        • Table Soft Mist Inhaler - Product Description
    • Spyryx Biosciences Inc Company Overview
      • Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPX-250 Dry Powder Inhaler - Product Status
        • Table SPX-250 Dry Powder Inhaler - Product Description
    • Sun Pharma Advanced Research Company Ltd Company Overview
      • Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPARC DPI - Product Status
        • Table SPARC DPI - Product Description
    • Syqe Medical Company Overview
      • Syqe Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syqe Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syqe Inhaler - Product Status
        • Table Syqe Inhaler - Product Description
    • Tetra Bio-Pharma Inc Company Overview
      • Tetra Bio-Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tetra Bio-Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rx Princeps Inhalation Device - Product Status
        • Table Rx Princeps Inhalation Device - Product Description
        • Table Tetra Bio-Pharma Inc - Ongoing Clinical Trials Overview
        • Table Rx Princeps Inhalation Device - Inhaled PPP001 versus Buccal Tablets for the Management of Breakthrough Pain in Cancer Patients: an Open Label, Crossover, Comparison Study Followed by a Randomized, Double-blind, Placebo-controlled Pilot Trial
        • Table Rx Princeps Inhalation Device - Safety and Efficacy of PPP001-kit for Improving Health Related Quality of Life in Advanced Cancer Patients with Uncontrolled Pain: A Randomized, Double-blind, Placebocontrolled, Parallel Group Study
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table New Inhaler Device Platform - Product Status
        • Table New Inhaler Device Platform - Product Description
        • Table ProAir Digihaler - Product Status
        • Table ProAir Digihaler - Product Description
        • Table Tidal Inhaler - Product Status
        • Table Tidal Inhaler - Product Description
    • United Therapeutics Corp Company Overview
      • United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tyvaso-ILD - Product Status
        • Table Tyvaso-ILD - Product Description
        • Table United Therapeutics Corp - Ongoing Clinical Trials Overview
        • Table Tyvaso-ILD - A Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease
        • Table Tyvaso-ILD - An Open-label Extension Study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease
    • University of Kansas Company Overview
      • University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status(University of Kansas)
        • Table Dry Powder Inhaler - Product Description(University of Kansas)
    • University of Sydney Company Overview
      • University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status(University of Sydney)
        • Table Dry Powder Inhaler - Product Description(University of Sydney)
    • University of Texas Medical Branch at Galveston Company Overview
      • University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Drug Delivery System - Product Status
        • Table Dry Powder Drug Delivery System - Product Description
    • Uscom Ltd. Company Overview
      • Uscom Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Uscom Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spirosonic SmartSpacer - Product Status
        • Table Spirosonic SmartSpacer - Product Description
    • Vectura Group Plc Company Overview
      • Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Digitally - Connected LOMI Device - Product Status
        • Table Digitally - Connected LOMI Device - Product Description
        • Table Open-Inhale-Close Dry Powder Inhaler - Product Status
        • Table Open-Inhale-Close Dry Powder Inhaler - Product Description
        • Table SKP-2075 - Product Status
        • Table SKP-2075 - Product Description
    • Verona Pharma Plc Company Overview
      • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RPL554 - Dry Powder Inhaler - Product Status
        • Table RPL554 - Dry Powder Inhaler - Product Description
        • Table Verona Pharma Plc - Ongoing Clinical Trials Overview
        • Table RPL554 - Dry Powder Inhaler - Phase 2 Trial to Evaluate the Ensifentrine DPI Formulation in Patients with Moderate-to-Severe COPD
    • Virginia Commonwealth University Company Overview
      • Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Device - Cystic Fibrosis - Product Status
        • Table Drug Delivery Device - Cystic Fibrosis - Product Description
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
  • Inhalers- Recent Developments
    • May 04, 2019: Vectura wins US GSK patent litigation and awarded $89.7Million in damages by trial jury
    • May 03, 2019: Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
    • May 02, 2019: Teva reports first quarter 2019 financial results
    • May 01, 2019: United Therapeutics reports first quarter 2019 financial results
    • May 01, 2019: GSK delivers sales of £7.7 billion +6% AER, +5% CER
    • Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact
    • Apr 30, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 March 2019
    • Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
    • Apr 25, 2019: Orion Group Interim report January-March 2019
    • Apr 24, 2019: Novartis starts 2019 with strong sales and double digit core operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
    • Apr 22, 2019: Cipla names Dr. Raju Mistry as Global Chief People Officer
    • Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
    • Apr 11, 2019: Fire at Orion's manufacturing plant in Turku
    • Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
    • Apr 09, 2019: Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off
    • Apr 08, 2019: NICE encourages use of greener asthma inhalers
    • Apr 02, 2019: Qualcomm announces, chief financial officer, George Davis, to leave company
    • Apr 02, 2019: Alcon announces Timothy Stonesifer as Chief Financial Officer
    • Apr 02, 2019: 3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility
    • Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors
    • Mar 31, 2019: Cipla: Product specific pre-approval (PAI) and Good Manufacturing Practices (GMP) inspection at its Kurkumbh plant
    • Mar 29, 2019: Circassia announces FDA approval of Tudorza supplemental New Drug Application
    • Mar 28, 2019: GlaxoSmithKline Pharmaceuticals: Change in directorate
    • Mar 28, 2019: GSK publishes product sales reporting changes and the impact of IFRS 16 'Leases'
    • Mar 26, 2019: Vectura Group 2018 preliminary results
    • Mar 22, 2019: Sosei Heptares announces that Ultibro Breezhaler and Seebri Breezhaler launched in China for the treatment of COPD
    • Mar 21, 2019: Aptar Pharma to showcase new market innovations at Interphex 2019, New York City
    • Mar 21, 2019: SeqOnce Biosciences launches RhinoSeq Rapid DNA Library Preparation Kit
    • Mar 19, 2019: Acorda to present new long-term data for INBRIJA (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual Meeting
    • Mar 18, 2019: 3M announces new business segments and leadership appointments
    • Mar 15, 2019: Adamis Pharmaceuticals announces 2018 financial results and provides business update
    • Mar 14, 2019: Novartis announces change in Sandoz leadership
    • Mar 14, 2019: Bellerophon provides business update and reports fourth quarter and fullyear 2018 financial results
    • Mar 14, 2019: Sandoz CEO steps down in latest Novartis management overhaul
    • Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community
    • Mar 04, 2019: Verona Pharma reports positive interim data with Ensifentrine dry powder inhaler formulation in first of two-part phase 2 clinical trial in COPD
    • Mar 04, 2019: Sunovion Pharmaceuticals appoints Dr. Antony Loebel as President and CEO
    • Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board
    • Mar 01, 2019: Actavis Laboratories receives Warning Letter from U.S FDA
    • Feb 28, 2019: Acorda Therapeutics Announces Commercial Launch of INBRIJA (levodopa inhalation powder)
    • Feb 28, 2019: Nektar Therapeutics reports fourth quarter and year-end 2018 financial results
    • Feb 28, 2019: Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
    • Feb 27, 2019: OtiTopic granted two patents covering its dry powder inhaled Aspirin for the treatment of suspected myocardial infarction
    • Feb 27, 2019: OPKO Health reports 2018 fourth quarter business highlights and financial results
    • Feb 27, 2019: United Therapeutics announces 2018 fourth quarter and annual financial results
    • Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed
    • Feb 22, 2019: Propeller Health study finds most asthma patients use inhalers incorrectly
    • Feb 21, 2019: Insilico and Teva enter collaboration to apply predictive digital twins for biopharmaceutical production
    • Feb 21, 2019: 84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds
    • Feb 20, 2019: MannKind presents new scientific data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)
    • Feb 19, 2019: Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
    • Feb 18, 2019: Mundipharma appoints Patrice Grand as European Director of Corporate Communications
    • Feb 15, 2019: Iconovo is hiring an Analytical Chemist to strengthen the full development cycle of medicinal inhalers and inhalation formulations
    • Feb 14, 2019: Pharmaxis financial and directors' reports for the six months ended 31 December 2018
    • Feb 13, 2019: Teva reports fourth quarter and full year 2018 financial results
    • Feb 12, 2019: Pulmatrix Receives Five Patents Supporting Claims for their Novel Inhaled Narrow Spectrum Kinase Inhibitor Programs
    • Feb 11, 2019: Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD
    • Feb 08, 2019: Prasco launches the Authorized generic of ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder)
    • Feb 08, 2019: Puerto Rican children with asthma less likely to use inhalers than Mexican american children
    • Feb 06, 2019: Orion Group financial statement release for 2018
    • Feb 06, 2019: 3M leadership announcement
    • Feb 06, 2019: GSK delivers sales, earnings and cash flow growth in 2018
    • Feb 05, 2019: Roger Lassing joins Iconovo as VP business development
    • Feb 01, 2019: Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
    • Jan 31, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 December 2018
    • Jan 29, 2019: 3M reports fourth-quarter 2018 results
    • Jan 23, 2019: Ology Bioservices appoints vaccines and biologics manufacturing industry veteran, Brandon Brega, as chief operating officer
    • Jan 21, 2019: GlaxoSmithKline announces resignation of Sir Philip Hampton as nonexecutive chairman
    • Jan 21, 2019: GSK announces succession plan to appoint new Chairman
    • Jan 17, 2019: Acorda announces the Lancet Neurology publication of phase 3 data for INBRIJA (levodopa inhalation powder)
    • Jan 16, 2019: MannKind announces direct purchase insulin program providing Afrezza for as low as $4 a Day
    • Jan 09, 2019: Recommendation by the nomination committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation
    • Jan 07, 2019: OPKO Health names Jon R. Cohen, M.D. executive chairman of BioReference Laboratories
    • Jan 03, 2019: Senzer's unique pharmaceutical inhaler wins prestigious global design award
    • Jan 03, 2019: Dance Biopharm Achieves Growth and Organizational Milestones in 2018 with Continued Development of Inhaled Biologics Pipeline
    • Dec 27, 2018: OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, announce proposed resolution of SEC action
    • Dec 24, 2018: Acorda Therapeutics announced FDA approval of INBRIJA
    • Dec 21, 2018: Teva announces FDA approval of first and only digital inhaler with built-in sensors - Proair Digihaler (albuterol sulfate 117 mcg) inhalation powder
    • Dec 20, 2018: Novartis announces new CEO of Oncology Business Unit
    • Dec 17, 2018: INSYS Therapeutics provides update on Dronabinol
    • Dec 17, 2018: Aptar Pharma to exhibit latest innovations at Pharmapack 2019, Paris
    • Dec 17, 2018: Medical Developments International: Retirement of Allan McCallum as a Director
    • Dec 13, 2018: First production completed for strong vape segment growth
    • Dec 13, 2018: Adherium restructures for growth
    • Dec 13, 2018: Update on UK GSK patent litigation
    • Dec 05, 2018: European Commission : Next-generation asthma inhalers
    • Dec 04, 2018: Consort Medical delivers profit growth in the first half
    • Dec 03, 2018: Johnston County commissioners approve incentives for latest Novo Nordisk expansion
    • Nov 30, 2018: Mundipharma announces Marco Cerato as Senior Vice President Business Development and Strategic Partnerships
    • Nov 28, 2018: Resolve Digital Health enters strategic partnership with Jamaican Medical Cannabis
    • Nov 28, 2018: Novartis to move UK headquarters to London in bold move to join emerging life sciences cluster
    • Nov 27, 2018: MannKind names Christine Mundkur as Board Director
    • Nov 21, 2018: Pulmatrix announces positive final results from the phase 1/1b clinical trial of Pulmazole - an inhaled dry-powder iSPERSE formulation of Itraconazole
    • Nov 20, 2018: Access to Medicine Index 2018 media statement
    • Nov 19, 2018: Uscom China receives notice of IP grants and publications
    • Nov 19, 2018: Mundipharma announces Chief Financial Officer
    • Nov 16, 2018: Otsuka Pharmaceutical Development & Commercialization, hosts roundtable on healthcare and technology with U.S. representative Bonnie Watson Coleman
    • Nov 15, 2018: Pulmatrix to present results from the Pulmazole (PUR1900) phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology
    • Nov 15, 2018: Novartis Calls for FDA Enforcement Against Biosimilar Misinformation
    • Nov 14, 2018: Nektar appoints Wei Lin, M.D., as Senior Vice President of clinical development and Head of Nektar's oncology programs
    • Nov 13, 2018: Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London
    • Nov 09, 2018: Once-daily Trelegy Ellipta gains expanded COPD indication in Europe
    • Nov 09, 2018: Adamis Pharmaceuticals announces third quarter 2018 financial results and business update
    • Nov 07, 2018: Bellerophon provides business update and reports third quarter 2018 financial results
    • Nov 07, 2018: Nektar Therapeutics reports financial results for the third quarter of 2018
    • Nov 06, 2018: UDG Healthcare: Director declaration 2018
    • Nov 06, 2018: Consort Medical announces its board change
    • Nov 02, 2018: Tufts CTSI and Novartis collaborate to foster innovative translational research
    • Nov 01, 2018: Novo Nordisk''s operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018
    • Nov 01, 2018: Nilda Mesa joins The United Therapeutics Board Of Directors
    • Nov 01, 2018: Teva reports third quarter 2018 financial results
    • Nov 01, 2018: MannKind reports 2018 third quarter financial results
    • Oct 31, 2018: United Therapeutics Corporation reports third quarter 2018 financial results
    • Oct 31, 2018: Boehringer Ingelheim achieves next expansion milestone in biologics production in the US
    • Oct 31, 2018: Boehringer Ingelheim announces growth in the Bay Area
    • Oct 31, 2018: GSK delivers Q3 sales of £8.1 billion, +3% AER, +6% CER
    • Oct 31, 2018: Adherium: Appendix 4C - Quarterly cash flow report to September 30th, 2018
    • Oct 31, 2018: Vectura Group: Directorate change
    • Oct 26, 2018: Pneuma Respiratory names J. Knox Singleton as Board Director
    • Oct 22, 2018: Vectura group has announced the board change
    • Oct 22, 2018: GlaxoSmithKline Pharmaceuticals delivers strong H1 performance; H1 Revenue up 8% and PAT higher by 21%
    • Oct 22, 2018: Softhale announces New Board Member
    • Oct 21, 2018: Teva and New Jersey Governor Murphy formalize North America headquarters move with ceremony in Israel
    • Oct 18, 2018: Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth
    • Oct 17, 2018: Ology Bioservices Strengthens Management Team with Addition of Timothy Cooke, Ph.D. as Senior Vice President of Commercial Business
    • Oct 15, 2018: Novo Nordisk names Ludovic Helfgott executive vice president Biopharm
    • Oct 11, 2018: FDA approves Stiolto Respimat supplemental new drug application (sNDA) to add data on COPD exacerbation reduction
    • Oct 08, 2018: GlaxoSmithKline names Publicis Media as global media agency
    • Oct 05, 2018: Mundipharma announces Philippe Bastide as Head of Biosimilars
    • Oct 04, 2018: Aptar Pharma introduces new respiratory drug delivery device
    • Oct 04, 2018: MannKind Presents Positive Afrezza STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes
    • Oct 04, 2018: 191 job losses announced at GSK at Ulverston
    • Oct 04, 2018: GSK to move to 'simplified' distribution model
    • Oct 04, 2018: Pharmaxis non-executive director Dr. Simon Buckingham to retire at 2018 annual general meeting
    • Oct 04, 2018: Cipla: Inspection by the United States Food and Drug Administration (USFDA) at the Goa manufacturing facility
    • Oct 03, 2018: MannKind presents new scientific data at 54th Annual Meeting of the European Association for the Study of Diabetes
    • Sep 25, 2018: Novartis to cut more than 2000 jobs in Switzerland and UK
    • Sep 25, 2018: Novartis proposes to exit Grimsby UK site by end of 2020 as part of global manufacturing network transformation
    • Sep 24, 2018: INSYS Therapeutics completes initial clinical study of Dronabinol Inhalation with innovative Breath Actuated Inhaler
    • Sep 21, 2018: Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe
    • Sep 20, 2018: Novo Nordisk to lay off 400 employees in Denmark and China
    • Sep 19, 2018: GSK grabs new drug development head from Boehringer
    • Sep 19, 2018: Changes in responsibility areas of the Orion Group executive management board
    • Sep 19, 2018: GSK nabs Boehringer Ingelheim's Chief Medical Officer Christopher Corsico
    • Sep 18, 2018: Pharmaxis names Edward Rayner as Board Director
    • Sep 17, 2018: Large European real-world study reports effects of Spiolto Respimat for people living with COPD in daily clinical practice
    • Sep 17, 2018: Aptar Pharma to launch PureHale and showcase its portfolio of connected devices at CPhI Worldwide
    • Sep 13, 2018: Acorda announces FDA extends INBRIJA NDA review period
    • Sep 13, 2018: Positive Afrezza clinical data from STAT Study published in Diabetes Technology & Therapeutics
    • Sep 13, 2018: Health Canada Reclassifies Tetra Bio-Pharma's Inhalation Device Making it Eligible for Reimbursement
    • Sep 13, 2018: AstraZeneca to present Symbicort Turbohaler at European Respiratory Society International Congress 2018
    • Sep 11, 2018: Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
    • Sep 11, 2018: Vectura Group: Interim Results
    • Sep 11, 2018: Nova Medical Centers opens occupational medicine clinic in El Paso, Texas
    • Sep 11, 2018: United States' FDA awards University-led team over $500,000
    • Sep 10, 2018: Glenmark secures marketing authorization in Germany for its generic version of Seretide Accuhaler
    • Sep 10, 2018: Orion names Johanna Ivaska as Head & Vice President of Oncology Research
    • Sep 05, 2018: GlaxoSmithKline cuts 650 jobs nationwide, including 100 in Research Triangle Park
    • Sep 01, 2018: Nektar Therapeutics strengthens Board of Directors with appointment of Veteran Biotechnology Executive Karin Eastham
    • Aug 24, 2018: Lupin's Nagpur facility receives Establishment Inspection Report from US FDA
    • Aug 21, 2018: Uscom: Annual Report 2018
    • Aug 14, 2018: Acorda announces management transitions
    • Aug 14, 2018: medi USA introduces the Genumedi PSS
    • Aug 14, 2018: Novartis names Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer
    • Aug 10, 2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update
    • Aug 08, 2018: Novo Nordisk's operating profit decreased by 8% in danish kroner and increased by 4% in local currencies in the first six months of 2018
    • Aug 08, 2018: Nektar Therapeutics reports financial results for the second quarter of 2018
    • Aug 07, 2018: Iain Mackay appointed GSK Chief Financial Officer
    • Aug 07, 2018: Opko Health announces second quarter 2018 financial results
    • Aug 02, 2018: Teva reports second quarter 2018 financial results
    • Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET
    • Aug 01, 2018: Boehringer Ingelheim achieves modest growth in the first half of 2018
    • Aug 01, 2018: Bellerophon provides business update and reports second quarter 2018 financial results
    • Aug 01, 2018: United Therapeutics reports second quarter 2018 financial results
    • Jul 31, 2018: Nu-Med Plus Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval
    • Jul 31, 2018: Adherium: Appendix 4C -Quarterly cash flow report to June 30th, 2018
    • Jul 25, 2018: GSK delivers improvements in sales, margins and cash flow in Q2 2018
    • Jul 18, 2018: Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company
    • Jul 18, 2018: Orion: Half-year financial report January-June 2018
    • Jul 17, 2018: Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
    • Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director
    • Jul 12, 2018: James Ford appointed GSK General Counsel
    • Jul 06, 2018: Sandoz and its affiliate, Novartis Pharmaceuticals voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance
    • Jul 02, 2018: Novartis plans to spin-off eye care unit into standalone entity
    • Jun 27, 2018: Qualcomm hires Mark Fields and Kornelis Smit to board of directors
    • Jun 25, 2018: Pulmatrix Announces Positive Top-Line Results from Parts 1 and 2 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
    • Jun 25, 2018: MannKind Set to Join Russell 3000 Index
    • Jun 23, 2018: Pulmatrix announces the formation of the Pulmazole Clinical Advisory Board to support future development
    • Jun 18, 2018: Acorda to Present Data for INBRIJA (levodopa inhalation powder) at 2nd Pan American Parkinson's Disease and Movement Disorders Congress
    • Jun 14, 2018: New Chiesi mobile app aims to help improve inhaler technique training for asthma and COPD patients on Fostair (beclometasone and formoterol)
    • Jun 14, 2018: Consort Medical delivered another year of good growth in revenue and profit
    • Jun 14, 2018: Fermion's new plant operational in Hanko-nearly 100% of production is exported
    • Jun 12, 2018: GSK announces changes to Vaccines and Global Manufacturing & Supply leadership
    • Jun 12, 2018: Cipla Quality Chemical Industries: Building capacity to mitigate the burden of cancer in Uganda
    • Jun 07, 2018: MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase
    • Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director
    • May 29, 2018: Acorda announces EMA validation of the MAA submission for INBRIJA (levodopa inhalation powder)
    • May 24, 2018: Adherium Announces Appointment of David Allinson as Chief Financial Officer
    • May 21, 2018: 3M forms sustainability and product stewardship organization
    • May 17, 2018: New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy as needed in mild asthma
    • May 17, 2018: Tetra Natural Health Signs a Supply Agreement with Namaste Technologies for the Marketing and Distribution of Rx Princeps, its Premium Medicinal Cannabis Product
    • May 16, 2018: Novartis announces changes to the Executive Committee
    • May 16, 2018: At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth
    • May 14, 2018: Medical Developments International: Trading Update
    • May 12, 2018: Novartis India announce MD Milan Paleja to step down
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report